We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Benchmark Holdings Plc | LSE:BMK | London | Ordinary Share | GB00BGHPT808 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.50 | 1.10% | 46.00 | 45.10 | 48.00 | 46.00 | 46.00 | 46.00 | 15,546 | 10:42:32 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 169.74M | -23.15M | -0.0313 | -14.54 | 336.41M |
TIDMBMK
RNS Number : 1795U
Benchmark Holdings PLC
31 March 2021
31 March 2021
BENCHMARK HOLDINGS PLC
("Benchmark" or the "Company" or the "Group")
DIRECTOR DEALINGS
The Company has been informed that Yngve Myhre, Non-Executive Director, purchased 50,000 ordinary shares of 0.1 pence each in Benchmark ("Ordinary Shares") at a price of 58 pence per share on 29 March 2021 and purchased 150,000 Ordinary Shares at a price of 59 pence per share on 30 March 2021, both purchases being made by Nima Invest AS, a company solely owned by Mr Myhre.
Following this transaction, Mr Myhre's total beneficial interest in the Company is 1,000,000 Ordinary Shares, representing approximately 0.15 per cent. of the Company's issued share capital.
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of a transaction by a person discharging managerial responsibilities.
1 Details of the person discharging managerial responsibilities / person closely associated a) Name Yngve Myhre through Nima Invest AS, a company solely owned by Mr Myhre. -------------------------- -------------------------------------- 2 Reason for the notification ------------------------------------------------------------------ a) Position/status Non-Executive Director -------------------------- -------------------------------------- b) Initial notification Initial notification /Amendment -------------------------- -------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ------------------------------------------------------------------ a) Name Benchmark Holdings plc -------------------------- -------------------------------------- b) LEI 2138001UQHM4VZGXUJ19 -------------------------- -------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ------------------------------------------------------------------ a) Description of the 0.1p ordinary shares financial instrument, type of instrument ISIN: GB00BGHPT808 Identification code -------------------------- -------------------------------------- b) Nature of the transaction Purchase of shares -------------------------- -------------------------------------- c) Price(s) and volume(s) Price(s) Volume(s) 58 pence 50,000 59 pence 150,000 -------------------------- -------------------------------------- d) Aggregated information - Aggregated volume 50,000 150,000 - Price 58 pence 59 pence - Aggregated total GBP29,000.00 GBP88,500.00 -------------------------- -------------------------------------- e) Date of the transaction 29 March 2021 30 March 2021 -------------------------- -------------------------------------- f) Place of the transaction London Stock Exchange, AIM -------------------------- --------------------------------------
-Ends-
Benchmark Holdings plc Tel: 020 7920 3150 Ivonne Cantu, Investor Relations Director Rachel Aninakwah, Communications Numis Tel: 020 7260 1000 Freddie Barnfield/ Duncan Monteith (NOMAD) MHP Katie Hunt / Reg Hoare /Alistair de Kare-Silver Tel: 020 3128 8742 07551 170 451 benchmark@mhpc.com Notes to Editors: Benchmark challenges the status quo in aquaculture. Since 2000, Benchmark has consistently worked to build a technology-rich platform in the areas of genetics, nutrition, animal health and knowledge services, to serve its customers, helping them take control of their biological environment to improve yield and efficiency in a sustainable way. The Company has leading positions in its core markets and established R&D, manufacturing and distribution capabilities to serve all the major aquaculture markets. Benchmark operates in 27 countries in five continents and as at 30 November 2018, it employed 1,080 people. For further information on Benchmark please visit www.benchmarkplc.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHZFLFXFXLXBBK
(END) Dow Jones Newswires
March 31, 2021 10:41 ET (14:41 GMT)
1 Year Benchmark Chart |
1 Month Benchmark Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions